Removing themselves from the work environment seems to be a beneficial approach for these patients. However, the available data on an annual FEV1 decline is conflicting.

After that symptomatic management with short- and long-acting, inhaled beta-agonists and perhaps corticosteroid inhalers may be necessary. Bronchodilators may be required for many months to improve symptoms. A short course of steroids does help those with severe symptoms.

It is vital that the patient stop smoking.